Lyka Labs Profit & Loss Annual

Trade
BSE: 500259 | NSE: LYKALABS | ISIN: INE933A01014 | Sector: Biotechnology & Drugs
147.00 +3.65 (2.55%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 111.1993.07194.0886.25
Total Revenue 111.1993.07194.0886.25
Costof Revenue Total 44.8537.5552.9737.97
Gross Profit 66.3455.52141.1148.28
Selling/ General/ Admin Expenses Total 26.7718.6118.0614.57
Depreciation/ Amortization 12.8014.1517.358.32
Unusual Expense( Income) 0.417.396.520.37
Other Operating Expenses Total 23.8620.0721.9014.04
Total Operating Expense 108.6997.77116.8075.27
Operating Income 2.50-4.7077.2810.99
Interest Inc( Exp) Net- Non- Op Total -48.91-3.65-1.17-2.49
Other Net 1.45-8.10-17.92-24.13
Net Income Before Taxes -0.93-13.1759.25-14.14
Provisionfor Income Taxes 1.69-0.0220.80-4.05
Net Income After Taxes -2.62-13.1538.44-10.09
Minority Interest 0.13-0.060.56-1.46
Net Income Before Extra Items -2.49-13.2139.00-11.55
Net Income -2.49-13.2139.00-11.55
Income Availableto Com Excl Extra Ord -2.49-13.2139.00-11.55
Income Availableto Com Incl Extra Ord -2.49-13.2139.00-11.55
Diluted Net Income -2.49-13.2139.00-11.55
Diluted Weighted Average Shares 3.152.882.872.87
Diluted EPS Excluding Extra Ord Items -0.79-4.5913.59-4.03
Diluted Normalized EPS -0.71-2.9215.07-3.77
Total Adjustmentsto Net Income --0.00-
Gain( Loss)on Saleof Assets ----7.54
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts